The Future of Empty Capsules….. COVID-19 & Its Impact….
The global empty capsules market is expected
to reach USD 2.57 billion by 2024,
according to a new report by Grand View Research, Inc. Key factors responsible
for the growth are the increase in the geriatric population, proliferation of
pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the
upsurge in the consumer preferences for capsules over tablets.
Multiple therapeutic
regimens are being followed across the globe in attempts to come up with a
reliable treatment for Covid-19. One line of treatment includes the use of
hydroxychloroquine, while a second treatment line focuses to use antiviral
drugs used in the disease management of HIV. Both these approaches have surged
demand from advanced antivirals and antimalarial drugs. This impacts the drug
manufacturers as an off label indication for these drug classes has to be
worked upon. At the moment, the WHO has not prescribed any of these approaches,
neither they have commented if one is better than the other. The report will
account for Covid19 as a key market contributor.
The rising geriatric population count and the associated
chronic conditions are expected to heighten the demand for the production of
capsule-centric medications in the pharmaceutical and nutraceutical application
areas. Moreover, the benefits associated with capsule consumption, such as ease
of swallowing, faster absorption rates, and increased palatability are also
expected to contribute significantly to the expansion of the market over the
forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and
cosmeceutical industries is expected to serve as a high impact rendering driver
for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic
conditions and hence the consumption of these products has significantly
increased over the past few years. For instance, nutraceuticals, such as
omega-3 fatty acids, help in the prevention of cardiovascular conditions and
the heightened accessibility to these low-cost vitamin supplements has reduced
the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the
highest revenue of nearly USD 1,172.3 million. This high revenue share is
attributed to the following factors: sufficient availability of gelatin for the
production process and the cost-effectiveness of gelatin capsules as compared
to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules
and pullulan or starch material capsules.
To Request Sample Copy of this report, click the link:
However, the non-gelatin capsules segment is expected to
emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024.
With the source of the non-gelatin capsules being vegetarian, the religious and
cultural issues experienced in connection with capsules containing
animal-derived inactive ingredients can be evaded; this factor is estimated to
be primarily responsible for the large consumer base of this market over the
forecast period.
Further key findings
from the study suggest:
·
In 2015, the antibiotic and antibacterial
drugs segment generated the largest revenue of USD 453.7 million owing to the
surge in prevalence of a range of infectious diseases and chronic conditions
worldwide. The vitamins and dietary supplements category is expected to exhibit
the fastest growth rate of 7.8% over the forecast period.
·
Global efforts to reduce malnutrition and
vitamin deficiencies by various social welfare organizations and government
agencies are expected to boost the usage rates over the forecast period.
·
In 2015, North America dominated the empty
capsules market with a revenue share of over 39.6% due to the high disease
burden, the access to the latest drugs in this region, and the high consumption
rate of nutraceutical and cosmeceutical products in this region. Increase in
the geriatric population susceptible to varied conditions and disorders coupled
with the burgeoning of various bacterial and viral infections is expected to
improve the market penetration of various antibiotics, multivitamin
supplements, and other drugs.
·
The Asia Pacific region is estimated to
grow with the highest CAGR of 7.9% over the forecast period. The increase in
healthcare expenditure and the rise in per-capita disposable incomes are
expected to improve the overall access to healthcare facilities and medicines
across several developing countries in this region. Moreover, the upsurge in
the prevalence of infectious diseases and chronic conditions in this region are
also expected to positively reinforce the market growth over the forecast
period.
·
The market dynamics indicate the presence
of strong competition amongst the key players, such as Capsugel, Inc., ACG
Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada
Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings
Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil
Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
·
Furthermore, the increase in the demand for
generic drugs and contract manufacturing services is expected to open up new
avenues for the market growth over the forecast period.
The global empty
capsules market was valued at USD 1.34 billion in 2015. Key factors responsible
for the growth include the increasing geriatric population, the high demand of
empty capsules in the pharmaceutical, nutraceutical, and cosmeceutical
industries, and the growing consumer preference for capsules over tablets.
The increased
prevalence of the geriatric population and the associated chronic conditions
imposes a high demand on the production of therapeutically-effective medicines
to treat chronic health conditions. Capsules in the solid dosage forms are
mostly preferred by the geriatric population due to the following reasons: they
are easy to swallow, they have faster dissolution times in comparison to other
oral dosage forms, and the decreased gastrointestinal irritation caused by
these dosage forms.
The capsules are
preferred by most of the consumers due to their fast disintegrating nature
resulting in quicker absorption rates and the use of tasteless and odorless
gelatin coating, which makes these capsules palatable. Most of the
neutraceuticals and cosmeceuticals are preferred in the capsule forms, such as
cod liver oil capsules and CosmoPod capsules, respectively. Aforementioned
advantages associated with capsule consumption are responsible for the high
global demand for the empty capsules in the pharmaceutical, nutraceutical, and
cosmeceutical industries.
Have any Query? Ask our Experts:
However, the rising
prices of the raw materials and the cultural and religious issues concerned
with the consumption of capsules containing animal-derived inactive
ingredients, such as porcine and bovine gelatin capsule shells, are the limiting
factors for the growth of this market.
Grand View Research has segmented the empty
capsules market by product, therapeutic application, end user:
Global empty capsules market, by
product (USD Million, 2013 - 2024)
·
Gelatin Capsules
·
Non-Gelatin capsules
Global empty capsules market by therapeutic
application (USD Million, 2013 - 2024)
·
Antibiotic and antibacterial drugs
·
Vitamin and dietary supplements
·
Antacids and antiflatulent preparations,
·
Antianemic preparations,
·
Anti-inflammatory and anti-rheumatic drugs,
·
Cardiac therapy drugs,
·
Cough and cold preparations
Global empty capsules market by
end-user (USD Million, 2013 - 2024)
·
Pharmaceutical industries
·
Nutraceutical industries
·
Cosmeceutical industries
·
Research laboratories
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment